| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |